Eric Stier Email Address

Senior Vice President, General Counsel, and Secretary of GenMark Diagnostics

GenMark provides multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care.

Eric Stier joined Truvian Sciences, Inc. as its Chief Legal Officer in May 2022. Prior to joining Truvian, Mr. Stier served as Senior Vice President, General Counsel and Secretary of GenMark Diagnostics, Inc. (Nasdaq: GNMK) from November 2012 until the end of 2021, including through GenMark's acquisition by Roche in April 2021 for approximately $1.8 billion. Prior to joining GenMark, Mr. Stier served as Associate General Counsel of Gen-Probe Incorporated (Nasdaq: GPRO), a publicly traded molecular diagnostics company, from August 2007 through its approximately $3.8 billion acquisition by Hologic, Inc. in August 2012. Prior to joining Gen-Probe, Mr. Stier served as a Corporate Associate with the law firm of Latham & Watkins LLP, from September 2002 to August 2007, in the firm’s Los Angeles and San Diego offices. Mr. Stier received a B.A. in Behavioral Science and Law from the University of Wisconsin-Madison and a J.D. with honors from the University of Wisconsin Law School.